Ftse Mib
34.891,62
0,32%
DAX
20.368,42
0,78%
S&P 500
5.992,93
0,29%
NASDAQ
19.921,39
0,28%
Bitcoin
100.538,48
-1,71%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Plus Therapeutics Inc (PSTV) Plus Therapeutics Inc (PSTV) Notizie

PSTV

Plus Therapeutics (PSTV)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PSTV
DataOraFonteTitoloSimboloCompagnia
17/12/202413:30GlobeNewswire Inc.Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Breast Cancer Patients with Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer SymposiumNASDAQ:PSTVPlus Therapeutics Inc
04/12/202413:30GlobeNewswire Inc.Plus Therapeutics to Showcase ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 San Antonio Breast Cancer SymposiumNASDAQ:PSTVPlus Therapeutics Inc
03/12/202413:30GlobeNewswire Inc.Plus Therapeutics Expands Strategic Agreement with Telix IsoTherapeutics Group for Rhenium-186 Radioisotope SupplyNASDAQ:PSTVPlus Therapeutics Inc
25/11/202413:30GlobeNewswire Inc.Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual ConferenceNASDAQ:PSTVPlus Therapeutics Inc
22/11/202413:30GlobeNewswire Inc.Plus Therapeutics to Present Positive FORESEE Clinical Trial Summary Demonstrating Utility of CNSide™ Cerebrospinal Fluid Assay in Diagnosis and Clinical Management of Patients with Leptomeningeal MetastasesNASDAQ:PSTVPlus Therapeutics Inc
21/11/202413:30GlobeNewswire Inc.Plus Therapeutics to Present Multi-Institutional Experience Using the CNSide™ Cerebrospinal Fluid Assay in Patients with Leptomeningeal MetastasesNASDAQ:PSTVPlus Therapeutics Inc
14/11/202422:15GlobeNewswire Inc.Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:PSTVPlus Therapeutics Inc
14/11/202422:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSTVPlus Therapeutics Inc
14/11/202422:11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PSTVPlus Therapeutics Inc
06/11/202413:30GlobeNewswire Inc.Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing PartnershipNASDAQ:PSTVPlus Therapeutics Inc
05/11/202413:30GlobeNewswire Inc.Plus Therapeutics to Announce Third Quarter Financial Results and Host Conference Call on November 14, 2024NASDAQ:PSTVPlus Therapeutics Inc
29/10/202412:30GlobeNewswire Inc.Plus Therapeutics Showcases Leptomeningeal Metastases Programs at the 2024 SNO Annual Meeting in Houston, TexasNASDAQ:PSTVPlus Therapeutics Inc
04/10/202422:11Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSTVPlus Therapeutics Inc
01/10/202413:30GlobeNewswire Inc.Plus Therapeutics Reports ReSPECT-GBM Clinical Trial Update at the 2024 Congress of Neurological Surgeons Annual MeetingNASDAQ:PSTVPlus Therapeutics Inc
18/09/202413:30GlobeNewswire Inc.Plus Therapeutics Showcases New Interim ReSPECT-GBM Phase 2 Trial Data at the 2024 Congress of Neurological Surgeons Annual MeetingNASDAQ:PSTVPlus Therapeutics Inc
17/09/202413:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSTVPlus Therapeutics Inc
04/09/202413:30GlobeNewswire Inc.Plus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:PSTVPlus Therapeutics Inc
23/08/202422:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PSTVPlus Therapeutics Inc
14/08/202422:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSTVPlus Therapeutics Inc
14/08/202422:16GlobeNewswire Inc.Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:PSTVPlus Therapeutics Inc
13/08/202413:30GlobeNewswire Inc.Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases ConferenceNASDAQ:PSTVPlus Therapeutics Inc
12/08/202413:30GlobeNewswire Inc.Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases ConferenceNASDAQ:PSTVPlus Therapeutics Inc
08/08/202413:30GlobeNewswire Inc.Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024NASDAQ:PSTVPlus Therapeutics Inc
25/07/202413:30GlobeNewswire Inc.Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO ConferenceNASDAQ:PSTVPlus Therapeutics Inc
12/07/202422:40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PSTVPlus Therapeutics Inc
10/07/202418:12Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PSTVPlus Therapeutics Inc
10/07/202413:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PSTVPlus Therapeutics Inc
02/07/202413:30GlobeNewswire Inc.Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of CancerNASDAQ:PSTVPlus Therapeutics Inc
07/06/202423:02Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PSTVPlus Therapeutics Inc
07/06/202413:30GlobeNewswire Inc.Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRITNASDAQ:PSTVPlus Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PSTV

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
TIT
Telecom Italia
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
RACE
Ferrari NV
BIT
CPR
Davide Campari
BIT
TRN
Terna Trasmissione Elett...
BIT
FCT
Fincantieri
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network